A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer

NCT04053205 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastric or Gastroesophageal Junction Cancer

Interventions

DRUG: Gentuximab
DRUG: Paclitaxel

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]